SCHEMBL98747

SCHEMBL98747

O=[N+]([O-])c1cc(CCBr)ccc1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.53
ALDH1A1 P00352 2/20 0.53
PTGES O14684 1/20 0.43
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
HTR1A P08908 1/20 0.41
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
PDCD1 Q15116 2/20 0.39
CD274 Q9NZQ7 2/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
POLB P06746 2/20 0.38
CYP19A1 P11511 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9590489 0.88 ALDH1A1 (0.56) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL101169 0.85 ALDH1A1 (0.53) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL3905288 0.83 ALDH1A1 (0.58) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL27559990 0.82 FFAR1 (0.53) TDP1ALDH1A1PDCD1CD274RAB9A
SCHEMBL279052 0.81 ALDH1A1 (0.56) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL3904427 0.81 ALDH1A1 (0.56) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL15860172 0.81 ALDH1A1 (0.56) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL98895 0.81 ALDH1A1 (0.56) TDP1ALDH1A1PTGESCRHBPCRHR2
SCHEMBL3276779 0.81 ALDH1A1 (0.49) TDP1ALDH1A1PTGESMAPTPTGS2
SCHEMBL11832023 0.80 ALDH1A1 (0.44) TDP1ALDH1A1PTGESCRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9072734-B2 Quaternary ammonium salt compounds TEIJIN PHARMA LIMITED (JP) 2015-07-07 US disclosed
EP-2426121-A1 QUATERNARY AMMONIUM SALT COMPOUND Teijin Pharma Limited (JP) 2012-03-07 EP disclosed
US-20120046467-A1 QUATERNARY AMMONIUM SALT COMPOUNDS TEIJIN PHARMA LIMITED (JP) 2012-02-23 US disclosed
CN-1066070-A Promote the new benzo-fused lactams that tethelin discharges MERCK & CO INC (US) 1992-11-11 CN disclosed
CN-1048546-A Substituted imidazo-fused 6 unit heterocycle as angiotensin II antagonism medicine MERCK & CO INC (US) 1991-01-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046467-A1 QUATERNARY AMMONIUM SALT COMPOUNDS ADRB2, AGTR2, ADRB3 TDP1 4429/4885ALDH1A1 1896/4885PTGES 4412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.